Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokinetics
- 1 February 2017
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (4) , 1062-1069
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Kv1.5 Blockers for the Treatment of Atrial Fibrillation: Approaches to Optimization of Potency and Selectivity and Translation to In Vivo PharmacologyCurrent Topics in Medicinal Chemistry, 2009
- New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic ValueJournal of Cardiovascular Pharmacology, 2008
- Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or FlutterNew England Journal of Medicine, 2007
- Newer antiarrhythmic agents for maintaining sinus rhythm in atrial fibrillation: simplicity or complexity?European Heart Journal Supplements, 2007
- Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) StudyCirculation, 2004
- Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on MortalityCirculation, 2003
- A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley studyThe American Journal of Medicine, 2002
- A population-based study of mortality among patients with atrial fibrillation or flutterThe American Journal of Medicine, 2002
- Amiodarone: ionic and cellular mechanisms of action of the most promising class III agentThe American Journal of Cardiology, 1999
- Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents.Circulation Research, 1993